Cellebrite CEO Thomas Hogan Receives Award, Sells 139,713 Shares

What Happened Thomas E. Hogan, CEO of Cellebrite DI Ltd. (CLBT), received 339,484 ordinary shares on Aug 11, 2026 upon certification of a performance share award (grant dated Sept 19, 2025). The filing shows an acquisition (award) at $0.00 for those shares. On Aug 12, 2026 Hogan sold 139,713 of those shares in open-market transactions for aggregate proceeds of $2,149,638 (weighted average price $15.39).

Key Details

• Transactions: Award vested and delivered on 2026-08-11 (339,484 shares, $0.00 acquisition); open-market sale on 2026-08-12 of 139,713 shares for total ≈ $2,149,638.
• Price details: weighted average sale price $15.39; individual sale prices ranged from $15.06 to $15.73 (per footnote).
• Footnotes: F1 = award vested when performance was certified (8/11/2026); F2 = some shares were withheld to satisfy tax withholding on the award; F3 = sale price is a weighted average and per-trade breakdown is available on request.
• Shares owned after transaction: not disclosed in this Form 4.
• Filing timeliness: Form 4 was filed 2026-08-13 covering events on 8/11 and 8/12 — appears timely under the two-business-day rule.

Context This report reflects a performance-based award vesting followed by a partial open-market sale. The award delivery (acquisition at $0) is different from a purchase; the subsequent sale is a routine disposition. Tax-withholding shares were surrendered per F2 (common when awards vest). The filing does not state motivation for the sale; it is factual reporting of the award delivery and the subsequent market sale.